** Citi upgrades target price on ALS Ltd ALQ.AX to A$23.8 from A$19.45, maintains "buy" tag
** Laboratory testing services provider on Tuesday reported a 17.2% jump in underlying NPAT to A$178.4 million for HY
** Citi says co's commodities segment surprised on the upside with sample volumes up "low double-digit" compared to last year
** Says co's revised forecast of 12% to 14% organic revenue growth for commodities division appears conservative; brokerage estimates 15% growth
** Macquarie hikes EPS estimates for ALS by 6% to 7% for fiscals 2027, 2028 and 2029 each
** Says stock has had a "strong run and multiple", but should be supported by co's strong earnings growth profile which is above market and global peers
** Brokerage retains "outperform" rating, target price A$22.85
** Stock up 38.4% YTD, as of last close
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))